Hadef & Partners advised NMDC Group (formerly known as National Marine Dredging Company PJSC) on the floating of NMDC Energy, the wholly owned subsidiary and energy arm of the NMDC Group. The initial public offering (IPO) of NMDC Energy is a sale by NMDC Group of a certain percentage of the NMDC Group shares in […]
Matouk Bassiouny & Hennawy (“MBH”) acted as legal counsel to Otsuka Holdings (“Otsuka”), a holding company, which operates various businesses such as pharmaceuticals, nutraceuticals and consumer products, in connection with the Commercial International Bank’s (“
White & Case has advised the founders of Brands for Less (BFL) on the US$360 million sale of 35 percent of its shares to The TJX Companies (TJX) in a deal which values BFL at an
Matouk Bassiouny & Hennawy (“MBH”) acted as the legal counsel to Noatum Maritime (“Noatum”) – a multinational group in transport and logistics services, and an Abu Dhabi Ports PJSC Group company – in connection with its acquisition
Matouk Bassiouny & Hennawy (“MBH”) acted as the lead legal counsel to Act Financial in connection with completing its EGP 1.04 billion IPO, marking the first offering to occur in the Egyptian stock market since 2022, resulting
White & Case advised Aramco on its acquisition of a 50 percent interest in Blue Hydrogen Industrial Gases Company (BHIG), a wholly-owned subsidiary of Air Products Qudra (“APQ”), itself a joint venture between Air Products and
Meysan acted as legal counsel to Markaz, the Lead Manager and Subscription Agent Kuwait Financial Centre, in relation to the successful issuance by Al-Tijari, Commercial Bank of Kuwait, of the Second Tranche of Basel III
Baker McKenzie has advised UltraTech Cement Middle East Investments Limited (“UltraTech“), a wholly owned subsidiary of UltraTech Cement Limited, a multinational cement company based in India and a member of the Aditya Birla Group, in
King & Spalding advised TVM Capital Healthcare on its $35 million investment into Boston Oncology Arabia, a manufacturer and distributor of biogeneric drugs operating in Saudi Arabia. The investment into Boston Oncology Arabia helps to increase
Clifford Chance has advised the Republic of Indonesia on the international aspects of its landmark US$2.35 billion global sukuk. The three-tranche offering comprises of US$750 million 5-year, US$1 billion 10-year and US$600 million 30-year (green)
